TEVA 2050 TEVA 2050 (Tolterodine Tartrate Extended-Release 2 mg)
Pill with imprint TEVA 2050 TEVA 2050 is Green, Capsule-shape and has been identified as Tolterodine tartrate extended-release 2 mg. It is supplied by Teva Pharmaceuticals USA Inc..
Tolterodine is used in the treatment of overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Tolterodine 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 2050 TEVA 2050
- TEVA 2050 TEVA 2050
- 2 mg
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC):
More about tolterodine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 50 Reviews – Add your own review/rating
- Drug class: urinary antispasmodics
- Tolterodine Extended-Release Capsules
- Tolterodine Tablets
- Tolterodine (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.